Immediate Impact
6 standout
Citing Papers
miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer
2023 Standout
Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy
2021 Standout
Works of Michael A. Kiselow being referenced
A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours
2010
Comparison between l-CHOP and an l-CHOP protocol with interposed treatments of CCNU and MOPP (l-CHOP-CCNU-MOPP) for lymphoma in dogs
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael A. Kiselow | 325 | 209 | 23 | 138 | 17 | 379 | |
| Andrea B. Flory | 392 | 245 | 30 | 159 | 20 | 433 | |
| T. Hoather | 312 | 165 | 16 | 117 | 14 | 350 | |
| John D. Chretin | 303 | 184 | 30 | 104 | 18 | 385 | |
| Paola Laganga | 308 | 154 | 54 | 107 | 17 | 381 | |
| Sara D. Allstadt | 308 | 143 | 51 | 165 | 16 | 390 | |
| Paola Valenti | 289 | 172 | 34 | 67 | 24 | 336 | |
| Kristen Weishaar | 344 | 194 | 59 | 110 | 26 | 443 | |
| Mary Lynn Higginbotham | 320 | 159 | 82 | 88 | 24 | 405 | |
| A. S. Moore | 282 | 134 | 41 | 88 | 16 | 394 | |
| Deborah A. O’Keefe | 303 | 166 | 59 | 67 | 12 | 406 |
All Works
Loading papers...